SE9003844D0 - NAERINGSTILLSATS - Google Patents

NAERINGSTILLSATS

Info

Publication number
SE9003844D0
SE9003844D0 SE9003844A SE9003844A SE9003844D0 SE 9003844 D0 SE9003844 D0 SE 9003844D0 SE 9003844 A SE9003844 A SE 9003844A SE 9003844 A SE9003844 A SE 9003844A SE 9003844 D0 SE9003844 D0 SE 9003844D0
Authority
SE
Sweden
Prior art keywords
glutamine
composition
derivative
freeze
precursor
Prior art date
Application number
SE9003844A
Other languages
Swedish (sv)
Other versions
SE9003844L (en
Inventor
R Kihlberg
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE9003844A priority Critical patent/SE9003844L/en
Publication of SE9003844D0 publication Critical patent/SE9003844D0/en
Priority to AU89313/91A priority patent/AU8931391A/en
Priority to PCT/SE1991/000810 priority patent/WO1992009277A1/en
Publication of SE9003844L publication Critical patent/SE9003844L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a composition for oral or parenteral use, characterized in that the composition contains free L-glutamine and also at least one derivative of L-glutamine and optionally at least one precursor to L-glutamine, the composition being prepared aseptically and freeze-dried in powder form and radiation-sterilized, or in the form of a solution which is stored at low temperature, preferably in deep-frozen form. The derivative preferably consists of peptides, such as glycyl-L-glutamine and/or L-alanyl-L-glutamine, and the precursor may consist of alpha-keto-glutaric acid or the salt/derivative thereof. The derivative may also consist of N-acetyl-L-glutamine. The composition may also contain other nutrient components, or technical auxiliary substances, such as carbohydrates, sugar alcohols, vitamins and/or amino acids, preferably in freeze-dried form. The invention also relates to the production of the composition and to a method of preparing a nutrient solution.
SE9003844A 1990-12-03 1990-12-03 NAERINGSTILLSATS SE9003844L (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9003844A SE9003844L (en) 1990-12-03 1990-12-03 NAERINGSTILLSATS
AU89313/91A AU8931391A (en) 1990-12-03 1991-11-28 Nutrient supply
PCT/SE1991/000810 WO1992009277A1 (en) 1990-12-03 1991-11-28 Nutrient supply

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003844A SE9003844L (en) 1990-12-03 1990-12-03 NAERINGSTILLSATS

Publications (2)

Publication Number Publication Date
SE9003844D0 true SE9003844D0 (en) 1990-12-03
SE9003844L SE9003844L (en) 1992-06-04

Family

ID=20381081

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003844A SE9003844L (en) 1990-12-03 1990-12-03 NAERINGSTILLSATS

Country Status (3)

Country Link
AU (1) AU8931391A (en)
SE (1) SE9003844L (en)
WO (1) WO1992009277A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121467D0 (en) * 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5292722A (en) * 1992-11-06 1994-03-08 Brigham And Women's Hospital Intravenous solution that diminishes body protein loss
EP0634168A1 (en) * 1993-01-29 1995-01-18 Kyowa Hakko Kogyo Co., Ltd. Nutritive composition
JPH06227974A (en) * 1993-01-29 1994-08-16 Kyowa Hakko Kogyo Co Ltd Nutritive composition
WO1995011019A1 (en) * 1993-10-22 1995-04-27 Research Corporation Technologies, Inc. Glutamine-containing ingestible composition
SE9303691D0 (en) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
JP3979543B2 (en) * 1994-01-31 2007-09-19 雪印乳業株式会社 Antiallergic agent and method for producing the same
GB2323030A (en) * 1997-03-12 1998-09-16 Essential Nutrition Ltd Dietary supplements for immunocompromised patients
AU4251300A (en) 1999-05-07 2000-11-21 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
WO2004032653A1 (en) * 2002-10-08 2004-04-22 Abbott Laboratories Methods and compositions for providing glutamine
DE102006018293A1 (en) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pediatric amino acid solution for parenteral nutrition
CN103936824B (en) * 2014-05-11 2016-01-13 孔凯明 The environment-friendly preparation method thereof of phthalyl glycyl-L-glutamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2529935A1 (en) * 1975-07-04 1977-01-13 Fresenius Chem Pharm Ind READY-TO-USE PACKED, BALANCED SYNTHETIC DIAETIC MIXTURE
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
EP0250559A1 (en) * 1985-12-18 1988-01-07 VEECH, Richard L. Parenteral nutrition therapy with amino acids
SE8704217D0 (en) * 1987-10-29 1987-10-29 Vinnars Erik Ab AMINO ACID COMPOSITION FOR PARENTERAL NUTRITION
SE8902544L (en) * 1989-07-17 1991-01-18 Kabivitrum Ab PREPARATION FOR NUTRITIONAL SUPPLY AND PREPARATION FOR IT
IE911351A1 (en) * 1990-04-23 1991-10-23 Res Corp Technologies Inc Soluble tyrosine and cysteine source for total parenteral¹nutrition

Also Published As

Publication number Publication date
SE9003844L (en) 1992-06-04
AU8931391A (en) 1992-06-25
WO1992009277A1 (en) 1992-06-11

Similar Documents

Publication Publication Date Title
SE9003844L (en) NAERINGSTILLSATS
HUP9903534A2 (en) Method and composition for enhanced parenteral nutrition
MX12880A (en) PROCEDURE FOR THE PRODUCTION OF A PREPARATION OF HUMAN PROTEIN, STABLE IN STORAGE AND PRODUCT OBTAINED
EP0322249A3 (en) Collagen products, processes for the preparation thereof and pharmaceutical compositions containing the same
AU5483390A (en) Enzymatic removal of a protein amino-terminal sequence
EP0402755A3 (en) L-carnitine magnesium citrate
HU9300067D0 (en) Crystals of growth hormone and method for producing them
DE69525955T2 (en) A PHARMACEUTICAL FORMULATION CONTAINING GROWTH HORMONE AND ISOLEUCIN
DE69900756D1 (en) USE OF HMG PROTEINS FOR THE PRODUCTION OF MEDICINAL PRODUCTS WITH CYTOTOXIC EFFECT
ATE69164T1 (en) MEDICATIONS FOR THE TREATMENT OF URAEMIA.
CO5570658A2 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF DIABETES
ATE393631T1 (en) PEPTIDE AND ITS COSMETIC OR DERMATOLOGICAL USE TO IMPROVE ADHESION BETWEEN SKIN CELLS
ATE365542T1 (en) LYOPHILIZABLE PHARMACEUTICAL PLACEBO COMPOSITION, PARTICULARLY BASED ON PROTEINS OR POLYPEPTIDES, TO IMIMATE A MEDICINAL PRODUCT
AU580350B2 (en) Process for synthesising peptides
DE69837719D1 (en) PREPARATION OF LACTALBUMIN
DE3561201D1 (en) Medicaments containing tripeptides
IT8322623A1 (en) INJECTABLE THERAPEUTIC COMPOSITIONS CONTAINING STABLE SALTS OF S-ADENOSYL-L-METHIONINE
AU9625498A (en) Organ specific nutrition
DE69525757D1 (en) A PHARMACEUTICAL FORMULATION CONTAINING GROWTH HORMONE AND LEUCINE
GB900115A (en) Improvements in or relating to trypsin solutions
EP0486964A3 (en) S(+)-phenyl-alkanoic acids and alpha-hydroxy-alkanoic acids containing complexes
IT1251427B (en) PROCEDURE FOR PREPARING PEPTIDE AND / OR PROTEIN PRODUCTS ENRICHED WITH COVALENTLY LINKED AMINO ACIDS
KR920700224A (en) New bioactive peptide and calcium metabolism modulator containing it as an active ingredient
Nazari The efficacy of fluid and freeze dried antitoxic sera during the Lifetime
JPH02215730A (en) Cell proliferation inhibitor

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9003844-9

Format of ref document f/p: F